Jan 18, 2022 Last Updated 6:25 PM, Jan 11, 2022

Webinar: Understanding How Oncolytic Viruses Tackle the Cold Tumor Space

 

 

WEBINAR: 
UNDERSTANDING HOW ONCOLYTIC VIRUSES TACKLE THE COLD TUMOR SPACE  

Jan. 26, 2021, 5.00 p.m.– 6.05 p.m. CET 
 

Register Now


GÉTICA organizes in collaboration with Replimune the international webinar Understanding How Oncolytic Viruses Tackle the Cold Tumor Space. This high-level webinar is designed so that attendees will learn how re-engineered viruses can be used as cancer therapies (e.g. RP1+n ) and how  RP1+n oncolytic viruses are being investigated in different cancer types (with a special interest in  squamous cell carcinoma of the skin).

Registration: Free 
chairs webinar
 
CHAIRS
  • Ana Arance, MD. GÉTICA President, Medical Oncologist, Hospital Clínic, Barcelona (Spain)
  • Ramón Alemany. Scientist, Catalan Institute of Oncology (ICO) Barcelona (Spain)
speakers webinar  
SPEAKERS
  • Robert Coffin, MD. Chief Research & Development Officer Replimune Inc. Massachusetts (USA)
  • Kevin Harrington, MD. Professor in Biological Cancer Therapies, The Institute of Cancer Research, London (UK)
  • Miguel F. Sanmamed, MD. Medical Oncologist, Clínica Universidad de Navarra, Pamplona (Spain)

HOSTED BY
 
GÉTICA, Spanish Group for Cancer Immuno-Biotherapy, aims at research and development of immunological and advanced therapies in cancer; the training of researchers and clinicians in these areas of knowledge and practice; the contribution to the dissemination of knowledge about these treatments.
Twitter
LinkedIn
Instagram
Replimune's mission is to revolutionize cancer treatment through comprehensive activation of a tumor-specific immune response.
 
Twitter
LinkedIn
Instagram